RxNorm Semantic Concepts Index

What is RxNorm?

RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.

The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "".

Concept ID (RxCUI) Name Term Type Term Type Description
100Blood group antibody WeeksDesignated preferred name (PT)
101Substance with direct thrombin inhibitor mechanism of actionDesignated preferred name (PT)
102cetirizine hydrochloride 1 MG/ML [Aller-Tec]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name
1036-mercaptopurineDesignated preferred name (PT)
104Apolipoprotein BDesignated preferred name (PT)
105Anorexiant agentDesignated preferred name (PT)
106TimololDesignated preferred name (PT)
107Product containing methylprednisolone and neomycin (medicinal product)Designated preferred name (PT)
108TrifluoperazineDesignated preferred name (PT)
109avagard (chlorhexidine gluconate 1 % / ethanol 61 % ) Topical LotionSynonym (SY)Synonym of another TTY, given for clarity.
1108-oxyquinolDesignated preferred name (PT)
111Vaginal CreamDose Form (DF)
112Vinca alkaloidDesignated preferred name (PT)
113WaxDesignated preferred name (PT)
114Phenol sulfotransferaseFull form of descriptor (FN)
115AscorbaseSynonym (SY)Synonym of another TTY, given for clarity.
116Aspartate transaminaseDesignated preferred name (PT)
117Alupent Inhalant ProductSemantic Branded Dose Form Group (SBDG)Brand Name + Dose Form Group
118Phenytek Oral ProductSemantic Branded Dose Form Group (SBDG)Brand Name + Dose Form Group
119benzethonium Cl 0.15 % / benzocaine 5 % Topical SpraySemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
120AtenololDesignated preferred name (PT)
121Adenosine triphosphate (ATP) citrate (pro-3S)-lyaseDesignated preferred name (PT)
122Phosphatidylinositol 3-kinaseFull form of descriptor (FN)
123biotin / niacinamide / panthenol / zinc pyrithione Medicated ShampooSemantic Clinical Drug Form (SCDF)Ingredient + Dose Form
124Product containing autonomic agentDesignated preferred name (PT)
125ODC - Orotidine-5'-monophosphate decarboxylaseSynonym (SY)Synonym of another TTY, given for clarity.
126Home produced spiritDesignated preferred name (PT)
127BIS-EMASynonym (SY)Synonym of another TTY, given for clarity.
128Abortifacient agentDesignated preferred name (PT)
129proparacaine hydrochloride 5 MG/ML [Minims Proxymetacaine hydrochloride]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name
130Siberian elm pollen extract 20000 UNT/mL Injectable SolutionPrescribable Name (PSN)Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
131Picea abies flower bud extractIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
132Alpha amino isobutyric acidDesignated preferred name (PT)
133Neomycin palmitateDesignated preferred name (PT)
134Smilax regelii root extractIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
135Frangula purshiana bark extractIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
136AbrinDesignated preferred name (PT)
137Lactobacillus acidophilus 10000000000 UNTSemantic Clinical Drug Component (SCDC)Ingredient + Strength
13821-deoxycortisolDesignated preferred name (PT)
139BenzethoniumDesignated preferred name (PT)
140CaspofunginIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
1413,5 T>2<Full form of descriptor (FN)
142hypromellose 0.5 % / phenylephrine 0.12 % Ophthalmic SolutionSynonym (SY)Synonym of another TTY, given for clarity.
143undecylenic acid 20 % Topical SpraySemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
144miconazole Vaginal Cream [Lagicam]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name
145Cefaclor anhydrousDesignated preferred name (PT)
146Piperazine derivativeDesignated preferred name (PT)
147B endorphinFull form of descriptor (FN)
148Beta-galactosidaseDesignated preferred name (PT)
149AcebutololFull form of descriptor (FN)
150HexosaminidaseDesignated preferred name (PT)
151Beta very low density lipoproteinSynonym (SY)Synonym of another TTY, given for clarity.
152BetaxololFull form of descriptor (FN)
153amiloride hydrochloride 5 MG / furosemide 40 MG Oral Tablet [Frusemek]Semantic Branded Drug (SBD)Ingredient + Strength + Dose Form + Brand Name
154NicoumaloneIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
155AcetopromazineFull form of descriptor (FN)
156Parakeet feathers specific IgEDesignated preferred name (PT)
157Biological substanceFull form of descriptor (FN)
1585-iodo-2'-deoxycytidineDesignated preferred name (PT)
159palmitamideIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
160camphor 4 % / menthol 10 % / methyl salicylate 30 % Topical SpraySemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
161Paracetamol-containing productDesignated preferred name (PT)
162AcetanilidSynonym (SY)Synonym of another TTY, given for clarity.
163Cholesterol in VLDL, betaFull form of descriptor (FN)
164acetateIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
165AcetokinaseDesignated preferred name (PT)
166anti-inhibitor coagulant complex Injection [Feiba]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name
167AcetazolamideFull form of descriptor (FN)
168Acetic acid glacialDesignated preferred name (PT)
169Sweet chestnutSynonym (SY)Synonym of another TTY, given for clarity.
170Orthoboric acidFull form of descriptor (FN)
171FloricalBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
172glycerin / petrolatum / phenylephrine / shark liver oil Rectal CreamSemantic Clinical Drug Form (SCDF)Ingredient + Dose Form
173AcetohexamideIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
174ciprofloxacin Otic Suspension [Otiprio]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name
1751-hydroxymethyltriazolamDesignated preferred name (PT)
176Diacetyl reductaseDesignated preferred name (PT)
177Acetolactate synthaseFull form of descriptor (FN)
178AcetoneFull form of descriptor (FN)
179LoncorBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
180Prunus cerasifera whole extractIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
181sodium hypochlorite 0.62 MG/MLSemantic Clinical Drug Component (SCDC)Ingredient + Strength
182Fatty-acid methyltransferaseDesignated preferred name (PT)
183Arogenate dehydrogenaseDesignated preferred name (PT)
184Carbohydrate deficient transferrin, asialo fractionFull form of descriptor (FN)
1852-methylacetoacetyl-CoA thiolaseDesignated preferred name (PT)
1863-ketoacyl-CoA thiolaseFull form of descriptor (FN)
187Acetyl-coenzyme A carboxylaseFull form of descriptor (FN)
188Acetyl-CoA acylaseFull form of descriptor (FN)
189Human leukocyte antigen DRw12Designated preferred name (PT)
1901 biotinyl-CoA synthetaseDesignated preferred name (PT)
191calcium hydroxideIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
192Beta-L-arabinosidaseDesignated preferred name (PT)
193acetylcarnitineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
194AcetylcholineDesignated preferred name (PT)
195Choline esterase IDesignated preferred name (PT)
196AnticholinesteraseDesignated preferred name (PT)
197NAC - N-acetyl cysteineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
198nadolol 40 MG / bendroflumethiazide 5 MG Oral TabletFull form of descriptor (FN)
199acetyldigoxinSynonym (SY)Synonym of another TTY, given for clarity.
200acetyleneIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
201Acid esteraseFull form of descriptor (FN)
202CarbimazoleFull form of descriptor (FN)
203MegaceBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
204N-Acetyl-beta-glucosaminidaseDesignated preferred name (PT)
205S protein complementDesignated preferred name (PT)
206N-acetylprocainamideDesignated preferred name (PT)
207Acetylserotonin methyltransferaseDesignated preferred name (PT)
208Corzide 40 MG / 5 MG Oral TabletPrescribable Name (PSN)Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
209PRED MILD 0.12 % Ophthalmic SuspensionSynonym (SY)Synonym of another TTY, given for clarity.
210AcetyltransferaseDesignated preferred name (PT)
211TopicyclineBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
212Hb 80(EF4), Asp-asnFull form of descriptor (FN)
213chlordiazepoxide hydrochloride 10 MG Oral Capsule [Libritabs]Synonym (SY)Synonym of another TTY, given for clarity.
214Acid lipaseDesignated preferred name (PT)
215PurgativeFull form of descriptor (FN)
216Child SilapapBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
21712 HR dextromethorphan HBr 50 MG / guaifenesin 400 MG / K+ guaiacolsulfonate 200 MG Extended Release Oral CapsuleSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
218ceFAZolinIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
219Acid phosphomonoesteraseSynonym (SY)Synonym of another TTY, given for clarity.
220Special CBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
221ZartanBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
222L-3-aminoisobutyrateFull form of descriptor (FN)
223Cefalexin-containing productSynonym (SY)Synonym of another TTY, given for clarity.
224DHAS - Dehydroepiandrosterone sulfateDesignated preferred name (PT)
225Liquifilm TearsBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
226Marcain HeavyBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
227CeruloplasminDesignated preferred name (PT)
228Venombin ADesignated preferred name (PT)
229dichlorobenzyl alcoholIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
230Genetically modified virusDesignated preferred name (PT)
231Dihydrodipicolinate synthaseFull form of descriptor (FN)
232MCFDesignated preferred name (PT)
233Dinoprost tromethamineFull form of descriptor (FN)
234dipipanoneFull form of descriptor (FN)
235Deoxyribonucleic acid beta-glucosyltransferaseFull form of descriptor (FN)
236acidulated phosphate fluorideIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
237LevomethadylIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
238estradiol 0.05 MG/Day Weekly Transdermal SystemPrescribable Name (PSN)Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
239AclarubicinFull form of descriptor (FN)
240Chlorphenamine-containing productDesignated preferred name (PT)
241AconitaseFull form of descriptor (FN)
242aconiteIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
243NH4Cl 200 MG / Guaifenesin 100 MG Oral TabletSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
244Cholesterol desmolaseSynonym (SY)Synonym of another TTY, given for clarity.
245Choline acetylaseSynonym (SY)Synonym of another TTY, given for clarity.
246Mephobarbital 90 MG / DPH 60 MG Oral TabletSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
247zinc pyrithione 2 MG/ML [Head & Shoulders]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name
248chloramphenicol 4 MG/ML Ophthalmic SolutionSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
249euflavineDesignated preferred name (PT)
250Fibrinogen Seattle IIDesignated preferred name (PT)
251ketotifen 1 MG / theophylline 200 MG Extended Release Oral TabletSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
252vitamin K3 10 MG Oral TabletSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
253Chymotrypsin A and BSynonym (SY)Synonym of another TTY, given for clarity.
254CilastatinIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
255AcrosinDesignated preferred name (PT)
256ephedrine hydrochloride 4.7 MG/MLTall Man Lettering Synonym (TMSY)Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs.
257Gentamicin acetyltransferase 1Designated preferred name (PT)
258ClenbuterolFull form of descriptor (FN)
259ClobetasolFull form of descriptor (FN)
260Glycerophosphocholine phosphodiesteraseDesignated preferred name (PT)
261Maalox Quick Dissolve Maximum Strength 1000 MG (Ca 400 MG) Chewable TabletSemantic Branded Drug (SBD)Ingredient + Strength + Dose Form + Brand Name
262Actin-binding proteinFull form of descriptor (FN)
263TositumomabIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
264TrichomycinFull form of descriptor (FN)
265Cobra venomDesignated preferred name (PT)
266CoccidioidinFull form of descriptor (FN)
267Methyl morphineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
268Acyl-CoA reductaseSynonym (SY)Synonym of another TTY, given for clarity.
269HDL2 - High density lipoprotein subfraction 2Full form of descriptor (FN)
270SpectinomycinDesignated preferred name (PT)
271ActinDesignated preferred name (PT)
272Charcoal activatedSynonym (SY)Synonym of another TTY, given for clarity.
273hylanIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
274ActomyosinSynonym (SY)Synonym of another TTY, given for clarity.
275Complement component C1Full form of descriptor (FN)
276Active C3bFull form of descriptor (FN)
277C6 - complement component 6Synonym (SY)Synonym of another TTY, given for clarity.
278C5b-9 - complement 5b-9 complexDesignated preferred name (PT)
279isoconazoleDesignated preferred name (PT)
280Acute phase reactantDesignated preferred name (PT)
281Aciclovir-containing productFull form of descriptor (FN)
282Ketorolac trometamolSynonym (SY)Synonym of another TTY, given for clarity.
283Acyl coenzyme ADesignated preferred name (PT)
284travoprost 0.004 % Ophthalmic SolutionDesignated preferred name (PT)
285CMPsialate pyrophosphorylaseFull form of descriptor (FN)
286LTA-4 hydrolaseSynonym (SY)Synonym of another TTY, given for clarity.
287lidamidineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
28817,21-hydroxyprogesteroneSynonym (SY)Synonym of another TTY, given for clarity.
289Tetracosactide-containing productSynonym (SY)Synonym of another TTY, given for clarity.
2906-aminopurineFull form of descriptor (FN)
291CKBB - Creatine kinase BB isoenzymeDesignated preferred name (PT)
292Maleylacetate reductaseDesignated preferred name (PT)
293TransphosphoribosidaseDesignated preferred name (PT)
294CryoglobulinDesignated preferred name (PT)
295meningococcal group A polysaccharideIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
296AdenosineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
297CyclandelateDesignated preferred name (PT)
298N-Methylglutamate synthaseFull form of descriptor (FN)
299methylnicotinateIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
300CyclopenthiazideFull form of descriptor (FN)
301MMDASynonym (SY)Synonym of another TTY, given for clarity.
302mofebutazoneIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
303ADA - Adenosine deaminaseFull form of descriptor (FN)
304ADPFull form of descriptor (FN)
305ProtocollagenDesignated preferred name (PT)
306Cytochrome p-450 enzymeFull form of descriptor (FN)
307etoricoxibDesignated preferred name (PT)
308Adenosine kinaseDesignated preferred name (PT)
309AMPSynonym (SY)Synonym of another TTY, given for clarity.
310Actinomycin DDesignated preferred name (PT)
311DDDSynonym (SY)Synonym of another TTY, given for clarity.
312ATPaseSynonym (SY)Synonym of another TTY, given for clarity.
313sodium chloride 0.9 % Nasal SolutionDesignated preferred name (PT)
314Ca^2+^-transporting adenosine triphosphataseSynonym (SY)Synonym of another TTY, given for clarity.
315benzalkonium 0.2 MG/ML / chloroxylenol 1 MG/ML / hydrocortisone 10 MG/ML Otic SolutionSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
316glycopyrrolate 1 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength
317Na^+^/K^+^-transporting adenosine triphosphataseDesignated preferred name (PT)
318ATP - Adenosine triphosphateSynonym (SY)Synonym of another TTY, given for clarity.
319DeodorantFull form of descriptor (FN)
320Norleucine aminotransferaseFull form of descriptor (FN)
3213',5'-cyclic AMP synthetaseSynonym (SY)Synonym of another TTY, given for clarity.
322MyokinaseFull form of descriptor (FN)
323AdenylosuccinaseSynonym (SY)Synonym of another TTY, given for clarity.
324IMP-aspartate ligaseFull form of descriptor (FN)
325DesmopressinDesignated preferred name (PT)
326oxaprozinFull form of descriptor (FN)
327DexolBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
328Palladium chlorideDesignated preferred name (PT)
329DextromoramideFull form of descriptor (FN)
330methacycline 300 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength
331DialysateSynonym (SY)Synonym of another TTY, given for clarity.
332Adipex-PBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
333adiphenineFull form of descriptor (FN)
334mebendazole 40 MG/MLSemantic Clinical Drug Component (SCDC)Ingredient + Strength
335Clodronic acidIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
336ImmunostimulantDesignated preferred name (PT)
337trimipramine 75 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength
338rRNA N-glycosidaseFull form of descriptor (FN)
339StilbestrolSynonym (SY)Synonym of another TTY, given for clarity.
340Digitalis glycosideDesignated preferred name (PT)
341anidulafunginFull form of descriptor (FN)
342Polyphosphate kinaseDesignated preferred name (PT)
343dihydroxyacetoneIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
344prenylamine lactateIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
345GQ1b ganglioside antibodyFull form of descriptor (FN)
346leuprolide 22.5 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength
347nitrogen 99.5 % Gas for InhalationPrescribable Name (PSN)Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
348oxygen 99.1 % Gas for InhalationPrescribable Name (PSN)Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
349lamoTRIgine 2 MG Chewable Dispersible TabletTall Man Lettering Synonym (TMSY)Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs.
350DiphenoxylateIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
351Diphtheria immunoglobulinSynonym (SY)Synonym of another TTY, given for clarity.
352DiprenorphineFull form of descriptor (FN)
353Tannic-12 SBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
354Adrenal cortical hormone-containing productFull form of descriptor (FN)
355RibokinaseDesignated preferred name (PT)
356Phosphoribulose epimeraseDesignated preferred name (PT)
357Thiazide diureticDesignated preferred name (PT)
358roxatidine acetatePrecise Ingredient (PIN)A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms.
359Accuzyme 830,000 UNT/GM / 10 % Topical OintmentPrescribable Name (PSN)Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
360S-Alkylcysteine lyaseFull form of descriptor (FN)
361salicinIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
362Adrenaline hydrochlorideSynonym (SY)Synonym of another TTY, given for clarity.
363tinzaparin Injectable Solution [Innohep]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name
364DoxycyclineDesignated preferred name (PT)
365SialooligosaccharideDesignated preferred name (PT)
366Substance with alpha adrenergic receptor agonist mechanism of actionSynonym (SY)Synonym of another TTY, given for clarity.
367Substance with alpha adrenergic receptor antagonist mechanism of actionDesignated preferred name (PT)
368Beta-1 adrenergic receptorDesignated preferred name (PT)
369Beta-2 adrenergic receptorDesignated preferred name (PT)
370Substance with beta adrenergic receptor agonist mechanism of actionSynonym (SY)Synonym of another TTY, given for clarity.
371Beta blockerDesignated preferred name (PT)
372edrophonium Injectable SolutionSemantic Clinical Drug Form (SCDF)Ingredient + Dose Form
373Sucrose glucosyltransferaseFull form of descriptor (FN)
374Substance with adrenergic receptor agonist mechanism of actionDesignated preferred name (PT)
375AdrenochromeFull form of descriptor (FN)
376CorticotrophinSynonym (SY)Synonym of another TTY, given for clarity.
377calcium iodized / peptone,dried / thyroid (USP) Oral TabletSemantic Clinical Drug Form (SCDF)Ingredient + Dose Form
378Elapid venomDesignated preferred name (PT)
379ascorbic acid / ferrous gluconate / vitamin B12 Oral TabletSemantic Clinical Drug Form (SCDF)Ingredient + Dose Form
380Sporothrix species antibodyFull form of descriptor (FN)
381torsemide Oral Tablet [Torem]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name
382EmetineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
383TioxidazoleFull form of descriptor (FN)
384AtomoxetineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
385fluocinonide Topical SolutionSemantic Clinical Drug Form (SCDF)Ingredient + Dose Form
386fosfestrol Oral Tablet [Honvan]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name
387hypromellose 0.32 % Ophthalmic SolutionSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
388Polymyxin B sulfateFull form of descriptor (FN)
389Mite specific IgGDesignated preferred name (PT)
390IV fluidFull form of descriptor (FN)
391Ubiquitin--protein ligaseFull form of descriptor (FN)
392EnfluraneDesignated preferred name (PT)
393Ribonucleic acid uridylyltransferaseSynonym (SY)Synonym of another TTY, given for clarity.
394AFT - AflatoxinSynonym (SY)Synonym of another TTY, given for clarity.
395VLDL - Very low density lipoprotein triglycerideFull form of descriptor (FN)
396EnzymeDesignated preferred name (PT)
397agarDesignated preferred name (PT)
398XamoterolDesignated preferred name (PT)
399EpimeraseDesignated preferred name (PT)
400AgglutininsFull form of descriptor (FN)
401GP120 V-FMS proteinDesignated preferred name (PT)
402ZOLMitriptan 5 MG/ACTUAT Nasal SprayTall Man Lettering Synonym (TMSY)Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs.
403sulfamethoxazole / trimethoprim Injectable Solution [Bactrim]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name
404Eritrityl tetranitrateSynonym (SY)Synonym of another TTY, given for clarity.
405DispermoxBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
406ErythroseFull form of descriptor (FN)
407Azinphos-ethylFull form of descriptor (FN)
408Cricetinae proteinSynonym (SY)Synonym of another TTY, given for clarity.
409Estramustine sodium phosphateDesignated preferred name (PT)
410EstrogenSynonym (SY)Synonym of another TTY, given for clarity.
411medical airDesignated preferred name (PT)
412diethylpropion 60 MG Extended Release Oral CapsuleSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
413Inosine monophosphate cyclohydrolaseDesignated preferred name (PT)
414Ethyl biscoumacetateDesignated preferred name (PT)
415Monobasic Pot phosphate 6 MMOL/ML Injectable SolutionSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
416ISOtretinoin 0.00025 MG/MG Topical GelTall Man Lettering Synonym (TMSY)Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs.
417Etynodiol diacetatePrecise Ingredient (PIN)A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms.
418EtorphineDesignated preferred name (PT)
419lidocaine 50 MG/MG / triamcinolone 0.25 MG/MG Topical OintmentSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
420cefatrizine 100 MG/ML Oral SuspensionSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
421cetrimide 15 MG/ML Topical SolutionSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
422glycerin 634 MG/ML Oral SolutionSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
423ajmalineFull form of descriptor (FN)
424resorcinol 20 MG/ML / salicylic acid 20 MG/ML / sodium thiosulfate 88 MG/ML Topical LotionSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
425Activated Christmas FactorSynonym (SY)Synonym of another TTY, given for clarity.
426Alpha-aminopropionic acidIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
427ALT - alanine aminotransferaseFull form of descriptor (FN)
428Alanine racemaseFull form of descriptor (FN)
429Alanyl-tRNA synthetaseSynonym (SY)Synonym of another TTY, given for clarity.
430AlbendazoleIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
431buclizine 12.5 MG / Hydroxyzine 10 MG / vit-B3 25 MG Oral TabletTall Man Lettering Synonym (TMSY)Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs.
432progabide 300 MG Oral TabletSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
433AlbuminFull form of descriptor (FN)
434sulfathiazole 500 MG Oral TabletSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
435Salbutamol-containing productSynonym (SY)Synonym of another TTY, given for clarity.
436lecithin 600 MG Oral CapsulePrescribable Name (PSN)Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
437alibendol 100 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength
438bromelains 45 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength
439ADH - Alcohol dehydrogenaseDesignated preferred name (PT)
440HLA AbSynonym (SY)Synonym of another TTY, given for clarity.
441ketanserin Topical GelSemantic Clinical Drug Form (SCDF)Ingredient + Dose Form
442Fish venomDesignated preferred name (PT)
443hydroxypropylcellulose 5 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength
444FlavoxateIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
445FluconazoleIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
446FlunitrazepamFull form of descriptor (FN)
447oxilofrine 32 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength
448Ethyl alcoholSynonym (SY)Synonym of another TTY, given for clarity.
449FluorometholoneDesignated preferred name (PT)
450Fludroxycortide-containing productSynonym (SY)Synonym of another TTY, given for clarity.
451propafenone 10 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength
452theophylline 40 MG/MLSemantic Clinical Drug Component (SCDC)Ingredient + Strength
453FormaldehydeFull form of descriptor (FN)
454FIGLUSynonym (SY)Synonym of another TTY, given for clarity.
455AlcoholFull form of descriptor (FN)
456FFP - Fresh frozen plasmaDesignated preferred name (PT)
457Fruit sugarSynonym (SY)Synonym of another TTY, given for clarity.
458Human follicle stimulating hormoneFull form of descriptor (FN)
459FumaraseDesignated preferred name (PT)
460AlcuroniumDesignated preferred name (PT)
461Aldehyde dehydrogenase (nicotinamide adenine dinucleotide ^+^)Full form of descriptor (FN)
462GAG-ONC proteinDesignated preferred name (PT)
463Galactose-1-phosphate uridyl transferaseFull form of descriptor (FN)
464Annexin IVFull form of descriptor (FN)
465Aldehyde-lyaseDesignated preferred name (PT)
466AldehydeFull form of descriptor (FN)
467Recombinant human soluble insulinSynonym (SY)Synonym of another TTY, given for clarity.
468BasaljelBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
469BradophenSynonym (SY)Synonym of another TTY, given for clarity.
470Substance with protein kinase inhibitor mechanism of actionDesignated preferred name (PT)
471Aldose reductaseFull form of descriptor (FN)
472Blasticidin-S deaminaseDesignated preferred name (PT)
473brain-derived neurotrophic factorIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
474General anesthetic agentsDesignated preferred name (PT)
475Substance with aldosterone receptor antagonist mechanism of actionDesignated preferred name (PT)
476E. coli exonuclease ISynonym (SY)Synonym of another TTY, given for clarity.
477diphenhydramine citrate 19 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength
478Oxytetracycline hydrochlorideFull form of descriptor (FN)
479AlfentaBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
480AlfentanilFull form of descriptor (FN)
481ThornFull form of descriptor (FN)
482ClavulanateSynonym (SY)Synonym of another TTY, given for clarity.
483acetaminophen 10 MG/MLSemantic Clinical Drug Component (SCDC)Ingredient + Strength
484Walnut tree dustDesignated preferred name (PT)
485D-glucoseSynonym (SY)Synonym of another TTY, given for clarity.
486chlorothen 0.6 MG/MLSemantic Clinical Drug Component (SCDC)Ingredient + Strength
487GlucosidaseFull form of descriptor (FN)
488Glutamate decarboxylaseDesignated preferred name (PT)
489L-glutathioneDesignated preferred name (PT)
490Glutathione S-alkyltransferaseDesignated preferred name (PT)
491GlycerolIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
492HydrostatBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
493PegintronBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
494Alkaline phosphomonoesteraseFull form of descriptor (FN)
495ThiocylBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
496AlkaloidFull form of descriptor (FN)
497PrialtBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
498AurothioglucoseFull form of descriptor (FN)
499Cottonseed meal toxinSynonym (SY)Synonym of another TTY, given for clarity.
500FerrlecitBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
501GramicidinDesignated preferred name (PT)
502FrigidermBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
503GuaiacolIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
504Alkylating agentDesignated preferred name (PT)
505DinitroglycerolSynonym (SY)Synonym of another TTY, given for clarity.
506GoserelinIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
507halofantrineFull form of descriptor (FN)
5085-ureidohydantoinDesignated preferred name (PT)
509HaloperidolFull form of descriptor (FN)
510HarmidineSynonym (SY)Synonym of another TTY, given for clarity.
511Human chorionic gonadotrophin, alpha subunitSynonym (SY)Synonym of another TTY, given for clarity.
512Hyocholic acidDesignated preferred name (PT)
513AllethrinDesignated preferred name (PT)
514He - HeliumIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
515HaematinDesignated preferred name (PT)
516allobarbitalFull form of descriptor (FN)
517Threo 2-amino 3-methylpentanoic acidSynonym (SY)Synonym of another TTY, given for clarity.
518Allophanate hydrolaseFull form of descriptor (FN)
519AllopurinolIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
520Allosteric siteDesignated preferred name (PT)
521HemopexinDesignated preferred name (PT)
522Hemostatic agentDesignated preferred name (PT)
523Hepatitis antibodyDesignated preferred name (PT)
524manganese gluconateIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
525AllylestrenolDesignated preferred name (PT)
526Methionine aminopeptidaseFull form of descriptor (FN)
527Metubine IodideBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
528AlmitrineDesignated preferred name (PT)
529almitrine dimesylatePrecise Ingredient (PIN)A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms.
530HexestrolDesignated preferred name (PT)
531Beta-N-acetylhexosaminidase BDesignated preferred name (PT)
532HexylresorcinolFull form of descriptor (FN)
533Diamine oxidaseSynonym (SY)Synonym of another TTY, given for clarity.
534A-1ACT - alpha-1-antichymotrypsinDesignated preferred name (PT)
535AAT - alpha-1-antitrypsinSynonym (SY)Synonym of another TTY, given for clarity.
536Histone kinaseSynonym (SY)Synonym of another TTY, given for clarity.
537Endothelium-derived relaxation factor-forming enzymeDesignated preferred name (PT)
538Human leukocyte antigen ASynonym (SY)Synonym of another TTY, given for clarity.
539HLA - Human leukocyte antigen B8Synonym (SY)Synonym of another TTY, given for clarity.
540A-2M - alpha-2 macroglobulinDesignated preferred name (PT)
541Interferon alfaFull form of descriptor (FN)
542guaifenesin 600 MG / phenylephrine hydrochloride 18 MG Extended Release Oral TabletSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
543Miltuss EXBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
544AFP - alpha-fetoproteinDesignated preferred name (PT)
545Alpha globulinDesignated preferred name (PT)
546brompheniramine / hydrocodone / pseudoephedrine Oral Solution [Bromplex HD]Tall Man Lettering Synonym (TMSY)Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs.
547HydralazineDesignated preferred name (PT)
548Chlorinated hydrocarbonFull form of descriptor (FN)
549PolicresulenFull form of descriptor (FN)
550dibasic potassium phosphateIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
551Prohormone converting enzymeFull form of descriptor (FN)
552HydroxychloroquineDesignated preferred name (PT)
553hydroxyestronesIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
554Hydroxymethylglutaryl-coenzyme A synthaseFull form of descriptor (FN)
555Hydroxycarbamide-containing productIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
556Rhizopus aspartic proteinaseSynonym (SY)Synonym of another TTY, given for clarity.
559Hypnotic agentDesignated preferred name (PT)
560alpha-amylaseIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
561sennoside BFull form of descriptor (FN)
562cephalexin Chewable TabletSemantic Clinical Drug Form (SCDF)Ingredient + Dose Form
563pirbuterol 1.5 MG/ML [Exirel]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name
564p-Isobutylhydratropic acidIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
565IdarubicinDesignated preferred name (PT)
566Immunoglobulin A1Designated preferred name (PT)
567IgG2 - Immunoglobulin G2Synonym (SY)Synonym of another TTY, given for clarity.
568ofloxacin 300 MG [Floxin]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name
569EflornithineDesignated preferred name (PT)
570acetaminophen 325 MG [Uni-Ace]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name
571Immunoglobulin fragmentDesignated preferred name (PT)
572Igs - ImmunoglobulinsFull form of descriptor (FN)
573Lambda light chainSynonym (SY)Synonym of another TTY, given for clarity.
574estradiol 0.0006 MG/MG [Oestrogel]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name
575MaltaseSynonym (SY)Synonym of another TTY, given for clarity.
576ezetimibe 10 MG [Zetia]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name
577estradiol 0.45 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength
578bromfenac 0.9 MG/MLSemantic Clinical Drug Component (SCDC)Ingredient + Strength
579Minor lactalbuminSynonym (SY)Synonym of another TTY, given for clarity.
580petrolatum 0.568 MG/MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength
581lactase 15 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength
582isopropyl alcohol 0.95 ML/MLSemantic Clinical Drug Component (SCDC)Ingredient + Strength
583Alpha-MSHFull form of descriptor (FN)
584Infant formulaDesignated preferred name (PT)
585Insulin solubleSynonym (SY)Synonym of another TTY, given for clarity.
586Active C14b2aSynonym (SY)Synonym of another TTY, given for clarity.
587Insulin proteaseSynonym (SY)Synonym of another TTY, given for clarity.
588Interferon alfa-2bDesignated preferred name (PT)
589B-cell growth factorSynonym (SY)Synonym of another TTY, given for clarity.
590EtazocineFull form of descriptor (FN)
591Gamma foetoproteinFull form of descriptor (FN)
592IF - Intrinsic factorFull form of descriptor (FN)
593chromium picolinateIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
594AlphaprodineDesignated preferred name (PT)
595algestoneIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
596AlprazolamDesignated preferred name (PT)
597AlprenololIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
598Prostaglandin PGE1Synonym (SY)Synonym of another TTY, given for clarity.
599AlseroxylonFull form of descriptor (FN)
600Human leucocyte antigen Bw75Synonym (SY)Synonym of another TTY, given for clarity.
601IsocarboxazidIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
602dorzolamideIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
603sodium phosphate 1500 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength
604Hb 22(B4), Glu-glnFull form of descriptor (FN)
605Donatussin MAXBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
606Moisture Eyes PMBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
607pregabalin 100 MG [Lyrica]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name
608meperidine Oral SolutionSemantic Clinical Drug Form (SCDF)Ingredient + Dose Form
609tocamphylIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
610Lymphocyte antigen CD66BFull form of descriptor (FN)
611Aluminum aspirinFull form of descriptor (FN)
612AlgeldrateIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
613Aluminium hydroxide gelFull form of descriptor (FN)
614ExjadeBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
615Aluminium oxideDesignated preferred name (PT)
616OrenciaBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
617Type IV collagenaseDesignated preferred name (PT)
618KynureninFull form of descriptor (FN)
619AmanitotoxinSynonym (SY)Synonym of another TTY, given for clarity.
620AmantadineFull form of descriptor (FN)
621Amantadine sulfateDesignated preferred name (PT)
622Product containing benzalkonium and cetrimide (medicinal product)Multiple Ingredients (MIN)Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD.
623AmbenoniumDesignated preferred name (PT)
624Ambestigmine chloridePrecise Ingredient (PIN)A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms.
625AmbroxolDesignated preferred name (PT)
626Mecillinam-containing productIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
627Pivmecillinam-containing productFull form of descriptor (FN)
628Absorbable gelatin spongeDesignated preferred name (PT)
629By AcheBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
630hydrofluoric acid 5 MG/MLSemantic Clinical Drug Component (SCDC)Ingredient + Strength
631citric acid 32.4 MG/ML / magnesium oxide 3.8 MG/ML / sodium carbonate 4.3 MG/ML [Urologic G]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name
632Mitomycin-CDesignated preferred name (PT)
633Hemofiltration solutionDesignated preferred name (PT)
635TransamidinaseSynonym (SY)Synonym of another TTY, given for clarity.
636Keratol HCBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
637LevallorphanIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
638Phosphoribosyldiphosphate 5-amidotransferaseDesignated preferred name (PT)
639Amidotrizoic acidDesignated preferred name (PT)
640linoleic acidPrecise Ingredient (PIN)A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms.
641AmikacinFull form of descriptor (FN)
642LipopolysaccharideDesignated preferred name (PT)
643Amikacin sulfateDesignated preferred name (PT)
644AmilorideDesignated preferred name (PT)
645Aminoacridine-containing productSynonym (SY)Synonym of another TTY, given for clarity.
646fluconazole 200 MG/MLSemantic Clinical Drug Component (SCDC)Ingredient + Strength
647LorazepamFull form of descriptor (FN)
648ferrous fumarate 322 MG / folic acid 350 MCG Oral TabletDesignated preferred name (PT)
651LymecyclineFull form of descriptor (FN)
652LymphokineFull form of descriptor (FN)
653LypressinDesignated preferred name (PT)
654Ethopropazine hydrochlorideSynonym (SY)Synonym of another TTY, given for clarity.
655acetaminophen / caffeine / salicylamide Oral CapsuleSemantic Clinical Drug Form (SCDF)Ingredient + Dose Form
656Amino-acid racemaseFull form of descriptor (FN)
657MafenideIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
658Magnesium hydrateSynonym (SY)Synonym of another TTY, given for clarity.
659Branched-chain amino acidDesignated preferred name (PT)
660Malic dehydrogenaseSynonym (SY)Synonym of another TTY, given for clarity.
661CervarixBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
662Dicarboxylic amino acidDesignated preferred name (PT)
663Essential amino acidFull form of descriptor (FN)
664KemstroBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
665Sulfur-bearing amino acidDesignated preferred name (PT)
666MaxataseFull form of descriptor (FN)
667diethylpropion Extended Release Oral Tablet [Tepanil]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name
668MedazepamIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
669MedrogestoneIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
670linezolid 400 MG Oral Tablet [Zyvox]Synonym (SY)Synonym of another TTY, given for clarity.
671MelarsoprolFull form of descriptor (FN)
672chlorpheniramine / hydrocodone / phenylephrine Oral Solution [NUDAL HD]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name
673Beta-alanine-oxoglutarate aminotransferaseDesignated preferred name (PT)
674PhosphoadenylylsulfataseBritish synonym (SYGB)British synonym of another TTY, given for clarity.
675MentholFull form of descriptor (FN)
676MeprobamateIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
677AminoglutethimideIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
678AminoglycosideDesignated preferred name (PT)
679Muconate cycloisomerase IISynonym (SY)Synonym of another TTY, given for clarity.
6804-hydroxybenzoate-CoA synthetaseDesignated preferred name (PT)
681piroxicam-beta-cyclodextrinDesignated preferred name (PT)
682AIB - Aminoisobutyric acidFull form of descriptor (FN)
683ALA - delta-aminolevulinic acidFull form of descriptor (FN)
684Aminolevulinate dehydrataseDesignated preferred name (PT)
685Aminolevulinate synthaseSynonym (SY)Synonym of another TTY, given for clarity.
686MethyclothiazideDesignated preferred name (PT)
687Peptidase aFull form of descriptor (FN)
688salicylic acid 0.03 MG/MG [Keralyt]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name
689AminophyllineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
690AQP-2Designated preferred name (PT)
691Beta-aminopropionitrileSynonym (SY)Synonym of another TTY, given for clarity.
692MetrizamideDesignated preferred name (PT)
693ethynodiol / mestranolMultiple Ingredients (MIN)Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD.
694benzocaine 63 MG/ML [Anbesol]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name
695AminophenazoneFull form of descriptor (FN)
696MidazolamIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
697LeucenineFull form of descriptor (FN)
698MinocyclineFull form of descriptor (FN)
699MisonidazoleFull form of descriptor (FN)
700cider vinegar 300 MG Oral TabletSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
701Lactobacillus bifidus 25 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength
702Substance with aminotransferase mechanism of actionSynonym (SY)Synonym of another TTY, given for clarity.
703AmiodaroneFull form of descriptor (FN)
704AmitriptylineDesignated preferred name (PT)
705cefixime 40 MG/ML [Suprax]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name
706Glucose dehydrogenaseFull form of descriptor (FN)
707Non-human hair - materialFull form of descriptor (FN)
708Ammonia-lyaseFull form of descriptor (FN)
709ammoniumIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
710Product containing codeine and guaiacol (medicinal product)Designated preferred name (PT)
711VyvanseBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
712Ammonium chlorideDesignated preferred name (PT)
713Erythropoetin deltaSynonym (SY)Synonym of another TTY, given for clarity.
714Product containing cefuroxime and metronidazole (medicinal product)Designated preferred name (PT)
715PrimperanBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
716Contact lens preparationsFull form of descriptor (FN)
717Sunless tanning lotionDesignated preferred name (PT)
718Myosin adenosine triphosphataseSynonym (SY)Synonym of another TTY, given for clarity.
719AmylobarbitoneSynonym (SY)Synonym of another TTY, given for clarity.
720AmodiaquineDesignated preferred name (PT)
721Arylamine sulfotransferaseBritish synonym (SYGB)British synonym of another TTY, given for clarity.
722AmoxapineFull form of descriptor (FN)
723AmoxicillinFull form of descriptor (FN)
724AMP aminaseFull form of descriptor (FN)
725Amfetamine-containing productSynonym (SY)Synonym of another TTY, given for clarity.
726guaiacolsulfonate / HYDROcodone Oral Solution [Atuss EX]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name
727Natriuretic hormoneSynonym (SY)Synonym of another TTY, given for clarity.
728Amphibian venomDesignated preferred name (PT)
729Superparamagnetic iron oxideFull form of descriptor (FN)
730Neomycin sulfateDesignated preferred name (PT)
731aluminum hydroxide 80 MG / magnesium trisilicate 14.2 MG Chewable TabletSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
732Amphotericin BIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
733AminobenzylpenicillinDesignated preferred name (PT)
734O-desmethylvenlafaxineSynonym (SY)Synonym of another TTY, given for clarity.
735Lysine racemaseDesignated preferred name (PT)
736Depolarizing agentFull form of descriptor (FN)
737paricalcitolDesignated preferred name (PT)
738Amrinone-containing productFull form of descriptor (FN)
739AmsacrineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
740NiclosamideFull form of descriptor (FN)
741TreandaBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
742Amyl nitriteFull form of descriptor (FN)
743AmylaseIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
744NitrazepamDesignated preferred name (PT)
745pantethine 300 MG Oral CapsuleSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
746Amyloid PFull form of descriptor (FN)
747PulmozymeBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
748AA proteinSynonym (SY)Synonym of another TTY, given for clarity.
749NAD^+^ pyrophosphorylaseFull form of descriptor (FN)
750nomifensineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
751lamoTRIgine 25 MG Oral Tablet 35 Count PackSynonym (SY)Synonym of another TTY, given for clarity.
752AmyloseDesignated preferred name (PT)
753PeranexBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
754AnabasineDesignated preferred name (PT)
755NubainBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
756AnafranilBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
757Central nervous system stimulantSynonym (SY)Synonym of another TTY, given for clarity.
758bismuth subsalicylate 262 MG Chewable Tablet (112) / metroNIDAZOLE 250 MG Oral Tablet (56) / tetracycline HCl 500 MG Oral Capsule (56) PackGeneric Pack (GPCK){# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack
759prussian blue insoluble 500 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength
760AnalgesicFull form of descriptor (FN)
761OchratoxinDesignated preferred name (PT)
762Kariva 28 Day PackPrescribable Name (PSN)Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
763insulin human, rDNA origin Dry Powder InhalerSemantic Clinical Drug Form (SCDF)Ingredient + Dose Form
764Arginine carboxypeptidaseFull form of descriptor (FN)
765OncoproteinDesignated preferred name (PT)
766AnaphylatoxinFull form of descriptor (FN)
767Ophthalmic SolutionDose Form (DF)
768SynflexBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
769AnaspazBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
770OrnidazoleDesignated preferred name (PT)
771AGP - alpha-1 acid glycoproteinSynonym (SY)Synonym of another TTY, given for clarity.
772Agkistrodon serine proteinaseDesignated preferred name (PT)
773Nonessential amino acidFull form of descriptor (FN)
774OsteonectinFull form of descriptor (FN)
775Substance with androgen receptor antagonist mechanism of actionSynonym (SY)Synonym of another TTY, given for clarity.
776G-strophanthinSynonym (SY)Synonym of another TTY, given for clarity.
777AndrogenDesignated preferred name (PT)
778OxazepamIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
779OxidoreductaseDesignated preferred name (PT)
780AndrostaneDesignated preferred name (PT)
781HbO2 - OxyhemoglobinFull form of descriptor (FN)
782OxipurinolFull form of descriptor (FN)
783saralasin acetatePrecise Ingredient (PIN)A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms.
784ADIONE - delta 4-androstenedioneFull form of descriptor (FN)
785PAI-1Full form of descriptor (FN)
786Water soluble vitaminSynonym (SY)Synonym of another TTY, given for clarity.
787tapentadolDesignated preferred name (PT)
788PancreatinIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
789SulfacitineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
790miconazole Topical Powder [Micatin]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name
791ParamethasoneFull form of descriptor (FN)
792ergonovine 0.2 MG [Ergotrate]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name
793PargylineFull form of descriptor (FN)
794ParvalbuminFull form of descriptor (FN)
795Compound 347Brand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
796PefloxacinDesignated preferred name (PT)
797thrombin Topical Solution [Thrombogen]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name
798Benzylpenicillin-containing productSynonym (SY)Synonym of another TTY, given for clarity.
799CotabfluBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
800Dianeal PD-2/4.25Brand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
801Sodium stibogluconateFull form of descriptor (FN)
802Pepsinogen 2Full form of descriptor (FN)
803chromic chloride 20.5 MCG (chromium 4 MCG) / copper sulfate 1.57 MG (copper 0.4 MG) / manganese sulfate 0.308 MG (manganese 0.1 MG) / zinc sulfate 4.39 MG (zinc 1 MG) per ML Injectable SolutionSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
804peptonesIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
805PerhexilineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
806Motrin 100 MG Oral TabletSynonym (SY)Synonym of another TTY, given for clarity.
807menthol 6.5 MG [Halls]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name
808pertussis vaccineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
809carbidopa 10 MG / levodopa 100 MG [Parcopa]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name
810lacosamide 50 MG Oral TabletFull form of descriptor (FN)
811phenacetinIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
812PhenazopyridineFull form of descriptor (FN)
813PhenindioneIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
814betamethasone / terfenadineMultiple Ingredients (MIN)Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD.
815PhenprocoumonFull form of descriptor (FN)
816PhenylbutazoneDesignated preferred name (PT)
817AnestheticFull form of descriptor (FN)
818guaifenesin / pyrilamineTall Man Lettering Synonym (TMSY)Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs.
819Local anestheticDesignated preferred name (PT)
820Anethole trithioneIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
821Phosphatidate phosphataseDesignated preferred name (PT)
822carisoprodol / dexamethasone / tenoxicamMultiple Ingredients (MIN)Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD.
823Phosphopyruvate carboxylase (GTP)Full form of descriptor (FN)
824Lecithinase AFull form of descriptor (FN)
825Phosphonacetic acidFull form of descriptor (FN)
826Zn(2+) G peptidaseFull form of descriptor (FN)
827Phosphorylase phosphataseFull form of descriptor (FN)
828Fosphenytoin sodiumFull form of descriptor (FN)
829methenamine mandelate 500 MG / sodium phosphate, monobasic 500 MG [Utac]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name
830bicalutamideFull form of descriptor (FN)
831Angiotensin 1Designated preferred name (PT)
832NexteroneBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
833desmopressin acetate 0.2 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength
834Angiotensin 3Full form of descriptor (FN)
835PipradrolDesignated preferred name (PT)
836Substance with angiotensin-converting enzyme inhibitor mechanism of actionFull form of descriptor (FN)
837AngiotonaseDesignated preferred name (PT)
838AngiotensinogenDesignated preferred name (PT)
839AngiotensinFull form of descriptor (FN)
840Plasma proteinFull form of descriptor (FN)
841T-PADesignated preferred name (PT)
842Platelet activating factorDesignated preferred name (PT)
843Platelet factor 4Full form of descriptor (FN)
844MinirinBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
845carbamazepine 200 MG Extended Release Oral Capsule [Equetro]Semantic Branded Drug (SBD)Ingredient + Strength + Dose Form + Brand Name
846benzoyl peroxide 5.25 % Medicated Liquid SoapPrescribable Name (PSN)Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
847vitamin K Oral CapsuleSemantic Clinical Drug Form (SCDF)Ingredient + Dose Form
848Humibid L.A. Reformulated Apr 2009Brand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
849redtop grass pollen extract 100000 UNT/MLSemantic Clinical Drug Component (SCDC)Ingredient + Strength
850amantadine hydrochloride 100 MG [Mantadine]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name
851Anion exchange resinFull form of descriptor (FN)
852Pectin depolymeraseDesignated preferred name (PT)
853quinidine gluconate 330 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength
854Polynucleotide phosphorylaseFull form of descriptor (FN)
855benzocaine 15 MG / menthol 4 MG Oral LozengeSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
856polysorbate 80Ingredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
857PVA - Polyvinyl alcoholIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
858PorphyrinFull form of descriptor (FN)
859guaiacolsulfonate 60 MG/ML / hydrocodone bitartrate 1 MG/ML [Hydone Formula Liquid]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name
860guaifenesin 60 MG/ML / hydrocodone bitartrate 0.7 MG/ML [Codiclear DH]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name
861AnserineDesignated preferred name (PT)
862Ant venomDesignated preferred name (PT)
863AntacidDesignated preferred name (PT)
864PrednisoneIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
865AntazolineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
866antazoline phosphatePrecise Ingredient (PIN)A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms.
867Acacia pollen extract 1000 UNT/MLSemantic Clinical Drug Component (SCDC)Ingredient + Strength
868Substance with anthelmintic mechanism of actionDesignated preferred name (PT)
869AnthocyaninFull form of descriptor (FN)
870ProcainamideIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
871Uridine diphosphate-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligaseFull form of descriptor (FN)
872ProflavineFull form of descriptor (FN)
873DithranolFull form of descriptor (FN)
874ProlixinBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
875Phosphoribosyl-anthranilate pyrophosphorylaseDesignated preferred name (PT)
876Anthranilate synthaseFull form of descriptor (FN)
877propiomazineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
878PropofolFull form of descriptor (FN)
879Product containing propylamine (product)Full form of descriptor (FN)
880Prostaglandin G/H synthaseDesignated preferred name (PT)
881F series prostaglandinDesignated preferred name (PT)
882Antirheumatic agentDesignated preferred name (PT)
883Antiarrhythmic agentDesignated preferred name (PT)
884Anti-infectivesSynonym (SY)Synonym of another TTY, given for clarity.
885Antiseptic agentFull form of descriptor (FN)
886ProteoglycanFull form of descriptor (FN)
887Antiinflammatory agentDesignated preferred name (PT)
888ProtoporphyrinDesignated preferred name (PT)
889Nonsteroidal anti-inflammatory agentSynonym (SY)Synonym of another TTY, given for clarity.
890aripiprazoleFull form of descriptor (FN)
891Calcium Chloride 0.000996 MEQ/ML / Glucose 1.4 MG/ML / Magnesium Chloride 0.0000245 MEQ/ML / NaCl 0.00368 MEQ/ML / Sodium Lactate 0.0016 MEQ/ML Intraperitoneal SolutionSynonym (SY)Synonym of another TTY, given for clarity.
892butafosfan 100 MG/MLSemantic Clinical Drug Component (SCDC)Ingredient + Strength
893Gamma-glu-X carboxypeptidaseDesignated preferred name (PT)
894Pulmonary surfactantDesignated preferred name (PT)
895Product containing purine nucleoside (product)Full form of descriptor (FN)
896AntibioticFull form of descriptor (FN)
897Substance with aminoglycoside structure and antibacterial mechanism of actionFull form of descriptor (FN)
898AnthracyclineFull form of descriptor (FN)
899sodium bitartrateIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
900Antineoplastic antibioticFull form of descriptor (FN)
901PyrimethamineFull form of descriptor (FN)
902pyritinolFull form of descriptor (FN)
903TL-Hist CDBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
904AntibodyFull form of descriptor (FN)
905Bifidobacterium Infantis 2000000 UNT/MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength
906ANADesignated preferred name (PT)
907Bacterial antibodySynonym (SY)Synonym of another TTY, given for clarity.
908Antibody to fungusDesignated preferred name (PT)
909Helminth antibodyDesignated preferred name (PT)
910Heterophile antibodyDesignated preferred name (PT)
911Monoclonal immunoglobulinDesignated preferred name (PT)
912Replacement preparationDesignated preferred name (PT)
913DiflorasoneFull form of descriptor (FN)
914Viral antibodySynonym (SY)Synonym of another TTY, given for clarity.
915Rattlesnake venomFull form of descriptor (FN)
916Adrenergic receptorFull form of descriptor (FN)
917Complement receptorFull form of descriptor (FN)
918Estradiol receptorFull form of descriptor (FN)
919Histamine H1 receptorFull form of descriptor (FN)
920Muscarinic receptorDesignated preferred name (PT)
921Steroid receptorFull form of descriptor (FN)
922Collyrium FreshBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
923AnticoagulantDesignated preferred name (PT)
924HYDROmorphone Rectal Suppository [Dilaudid]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name
925DrisdolBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
926AnticonvulsantFull form of descriptor (FN)
927AntidepressantDesignated preferred name (PT)
928Tricyclic antidepressantFull form of descriptor (FN)
929Antidiarrheal agentFull form of descriptor (FN)
930AntidoteDesignated preferred name (PT)
931Antiemetic agentFull form of descriptor (FN)
932Mag-Ox 400Brand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
933glyBURIDE Oral Tablet [Micronase]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name
934Naphcon forteBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
935NolahistBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
936OphthocortBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
937Pediaflor DropsBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
938citric acid / potassium citrate Oral Solution [Polycitra-K]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name
939medroxyPROGESTERone Oral Tablet [Provera]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name
940CIC - Circulating immune complexDesignated preferred name (PT)
941Slo-bid GyrocapsBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
942Sus-Phrine InjectionBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
943Antigenic determinantDesignated preferred name (PT)
944perphenazine Injectable Solution [Trilafon]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name
945methoxamine Injectable Solution [Vasoxyl]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name
946AntigenFull form of descriptor (FN)
947Antigen of bacteriaFull form of descriptor (FN)
948Cluster of differentiation antigenSynonym (SY)Synonym of another TTY, given for clarity.
949Leukocyte 3aSynonym (SY)Synonym of another TTY, given for clarity.
950Rutoside-containing productFull form of descriptor (FN)
951chloramphenicol Ophthalmic OintmentSemantic Clinical Drug Form (SCDF)Ingredient + Dose Form
952SalicylanilideFull form of descriptor (FN)
953Artificial saliva agentDesignated preferred name (PT)
954Antigen of FungusFull form of descriptor (FN)
955Helminth antigenDesignated preferred name (PT)
956Heterophil antigenDesignated preferred name (PT)
957ichthammol 20 % Topical OintmentSynonym (SY)Synonym of another TTY, given for clarity.
959Fibrous proteinDesignated preferred name (PT)
960Hyoscine-containing productIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
961Antigen of ProtozoaSynonym (SY)Synonym of another TTY, given for clarity.
962QuinalbarbitoneIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
963Thymus-independent antigenFull form of descriptor (FN)
964seleniteIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
965Antigen of virusSynonym (SY)Synonym of another TTY, given for clarity.
966levothyroxine sodium 0.025 MG Oral Tablet [Eltroxin]Semantic Branded Drug (SBD)Ingredient + Strength + Dose Form + Brand Name
967SerentilBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
968Antihypertensive agentDesignated preferred name (PT)
969miconazole Buccal TabletSemantic Clinical Drug Form (SCDF)Ingredient + Dose Form
970Buccal TabletDose Form (DF)
971Anti lymphocyte antibodyFull form of descriptor (FN)
972Anas platyrhynchos allergenic extractSynonym (SY)Synonym of another TTY, given for clarity.
973Antilymphocyte immunoglobulinFull form of descriptor (FN)
974Product containing Salmonella typhimurium antiserum (medicinal product)Full form of descriptor (FN)
975Substance with antimalarial mechanism of actionFull form of descriptor (FN)
976AntimetaboliteFull form of descriptor (FN)
977N-methyl-L-amino-acid oxidaseFull form of descriptor (FN)
978Substance with mitotic inhibitor mechanism of actionFull form of descriptor (FN)
979Prephytoene-diphosphate synthaseSynonym (SY)Synonym of another TTY, given for clarity.
980SincalideIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
981Antimony potassium tartrateDesignated preferred name (PT)
982Nucleoside phosphoacylhydrolaseFull form of descriptor (FN)
983Antimony sodium tartrateFull form of descriptor (FN)
984Substance with muscarinic receptor antagonist mechanism of actionSynonym (SY)Synonym of another TTY, given for clarity.
985Complement component, precursorFull form of descriptor (FN)
986Cephalothin sodiumBritish preferred term (PTGB)
987Blood group antigen HofDesignated preferred name (PT)
988Antineoplastic agentDesignated preferred name (PT)
989Blood group antibody BocFull form of descriptor (FN)
990Benzylpenicillin sodiumDesignated preferred name (PT)
991Sodium taurocholateFull form of descriptor (FN)
992Blood group antigen Sp>1<Designated preferred name (PT)
993Blood group antibody Pr>a<Full form of descriptor (FN)
994Blood group antigen HaaseDesignated preferred name (PT)
995Antiparkinsonian agentDesignated preferred name (PT)
996Alpha-2-antiplasminDesignated preferred name (PT)
997Blood group antibody CrossDesignated preferred name (PT)
998Substance with antiprotozoal mechanism of actionFull form of descriptor (FN)
999SpiperoneFull form of descriptor (FN)